Argus Reaffirms Buy Rating for Healthpeak Properties (NYSE:DOC)

Healthpeak Properties (NYSE:DOC)‘s stock had its “buy” rating reissued by analysts at Argus in a report issued on Tuesday,Benzinga reports. They presently have a $25.00 target price on the real estate investment trust’s stock. Argus’ price target would indicate a potential upside of 39.98% from the stock’s current price.

A number of other research analysts also recently issued reports on DOC. Evercore ISI decreased their price objective on Healthpeak Properties from $23.00 to $21.00 and set an “outperform” rating for the company in a report on Monday. Robert W. Baird decreased their price objective on Healthpeak Properties from $24.00 to $22.00 and set an “outperform” rating for the company in a report on Tuesday. StockNews.com downgraded Healthpeak Properties from a “hold” rating to a “sell” rating in a report on Wednesday, April 23rd. Wedbush decreased their price objective on Healthpeak Properties from $24.00 to $22.00 and set an “outperform” rating for the company in a report on Monday. Finally, Morgan Stanley upgraded Healthpeak Properties from an “equal weight” rating to an “overweight” rating and set a $25.00 price objective for the company in a report on Wednesday, January 15th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and nine have issued a buy rating to the company’s stock. According to data from MarketBeat, Healthpeak Properties presently has an average rating of “Moderate Buy” and an average target price of $23.42.

Healthpeak Properties Stock Up 0.6 %

Shares of Healthpeak Properties stock opened at $17.86 on Tuesday. Healthpeak Properties has a 1 year low of $17.33 and a 1 year high of $23.26. The business has a 50-day moving average of $19.46 and a two-hundred day moving average of $20.49. The company has a market capitalization of $12.49 billion, a P/E ratio of 51.03, a price-to-earnings-growth ratio of 2.17 and a beta of 1.02. The company has a debt-to-equity ratio of 0.96, a current ratio of 1.35 and a quick ratio of 1.35.

Healthpeak Properties (NYSE:DOC) last announced its quarterly earnings results on Thursday, April 24th. The real estate investment trust reported $0.46 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.46. Healthpeak Properties had a return on equity of 2.61% and a net margin of 9.00%. The company had revenue of $702.89 million during the quarter, compared to the consensus estimate of $690.76 million. During the same period in the prior year, the company earned $0.45 earnings per share. The company’s revenue for the quarter was up 15.9% compared to the same quarter last year. As a group, equities analysts predict that Healthpeak Properties will post 1.86 EPS for the current year.

Insider Activity at Healthpeak Properties

In related news, CEO Scott M. Brinker acquired 11,337 shares of the company’s stock in a transaction dated Monday, April 28th. The shares were bought at an average cost of $17.68 per share, with a total value of $200,438.16. Following the completion of the transaction, the chief executive officer now directly owns 201,863 shares of the company’s stock, valued at $3,568,937.84. This trade represents a 5.95 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director John T. Thomas acquired 4,200 shares of the company’s stock in a transaction dated Monday, April 28th. The stock was bought at an average cost of $17.84 per share, for a total transaction of $74,928.00. Following the completion of the transaction, the director now directly owns 813,566 shares of the company’s stock, valued at approximately $14,514,017.44. This trade represents a 0.52 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders own 0.23% of the company’s stock.

Hedge Funds Weigh In On Healthpeak Properties

Large investors have recently modified their holdings of the stock. JPMorgan Chase & Co. raised its position in shares of Healthpeak Properties by 23.2% in the third quarter. JPMorgan Chase & Co. now owns 21,561,640 shares of the real estate investment trust’s stock valued at $493,115,000 after purchasing an additional 4,056,931 shares during the period. Diamant Asset Management Inc. bought a new position in shares of Healthpeak Properties in the third quarter valued at about $564,000. Vert Asset Management LLC grew its stake in shares of Healthpeak Properties by 11.1% in the fourth quarter. Vert Asset Management LLC now owns 304,219 shares of the real estate investment trust’s stock valued at $6,167,000 after acquiring an additional 30,461 shares in the last quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund grew its stake in shares of Healthpeak Properties by 25.7% in the fourth quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund now owns 109,200 shares of the real estate investment trust’s stock valued at $2,213,000 after acquiring an additional 22,300 shares in the last quarter. Finally, Mirae Asset Global Investments Co. Ltd. grew its stake in shares of Healthpeak Properties by 16.6% in the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 110,498 shares of the real estate investment trust’s stock valued at $2,217,000 after acquiring an additional 15,753 shares in the last quarter. 93.57% of the stock is owned by institutional investors.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.